ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,463.54
      0.08%
      US Tech 100
      18,578.00
      0.12%
      Dow Jones
      40,539.93
      -0.12%
      Brent Oil
      78.88
      -0.33%
      Bitcoin
      66,548.07
      -0.41%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Australia
      5. ASX

      6. Noxopharm Limited (NOX) Quote

      Noxopharm Limited

      Noxopharm Limited (NOX)

      ASX
      0.069
      0.00
      (0.00%)
      Closed July 30 2:00AM
      Delayed by 20 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      0.069
      Bid
      0.069
      Ask
      0.074
      Volume
      8,493
      0.069 Day's Range 0.072
      0.033 52 Week Range 0.165
      Market Cap
      20.164M
      Previous Close
      0.069
      Open
      0.072
      Last Trade
      6993
      @
      0.069
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      113,613
      Shares Outstanding
      292,237,950
      Dividend Yield
      -
      PE Ratio
      -1.36
      Earnings Per Share (EPS)
      -0.05
      Revenue
      6.01M
      Net Profit
      -15.06M

      About Noxopharm Limited

      Sector
      Drugs And Proprietary-whsl
      Industry
      Drugs And Proprietary-whsl
      Website
      www.noxopharm.com
      Headquarters
      Sydney, New South Wales, Aus
      Founded
      1970
      Noxopharm Limited is listed in the Drugs And Proprietary-whsl sector of the Australian Stock Exchange with ticker NOX. The last closing price for Noxopharm was AUD0.07. Over the last year, Noxopharm shares have traded in a share price range of AUD 0.033 to AUD 0.165.

      Noxopharm currently has 292,237,950 shares outstanding. The market capitalization of Noxopharm is AUD20.16 million. Noxopharm has a price to earnings ratio (PE ratio) of -1.36.

      NOX Latest News

      More News

      FeaturedCannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA

      22 hours ago

      FDA Grants Orphan Drug Designation to Noxopharm for Sarcoma Treatment

      Australian biotech company Noxopharm (ASX:NOX) has announced the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation (ODD) to Veyonda®, its lead oncology drug candidate, for...

      March 29 2022
      Business Wire

      Sarcoma Trial for New Cancer Treatment Begins at City of Hope in Los Angeles

      Australian clinical-stage drug development company Noxopharm (ASX:NOX) has announced its Phase 1 CEP-2 sarcoma trial is underway with a first patient enrolled and dosed at City of Hope in Los...

      March 08 2022
      Business Wire

      Noxopharm In-Licenses Novel RNA Technology From Hudson Institute of Medical Research

      Exclusive deal for cutting-edge RNA technology in drug discovery and vaccines Australian clinical-stage drug development company Noxopharm (ASX:NOX) has in-licensed novel RNA technology...

      December 01 2021
      Business Wire

      Noxopharm Announces DARRT-2 Clinical Trial in U.S.

      Experimental Immunotherapy Cancer Treatment Enters Phase 2 Australian clinical-stage drug development company Noxopharm (ASX:NOX) has announced its DARRT-2 Phase 2 clinical trial has commenced...

      November 09 2021
      Business Wire

      ノクソファームの前臨床データがCOVID-19の治療におけるイドロノキシルの抗炎症作用をさらに裏付ける

      （ビジネスワイヤ） -- オーストラリアの臨床段階医薬品開発企業であるノクソファーム（ASX:NOX）は、治験薬の抗がん剤でビヨンダの有効成分となっているイドロノキシルが、早期COVID-19の治療における抗炎症薬...

      August 27 2021
      Business Wire

      Les données précliniques de Noxopharm confirment le rôle anti-inflammatoire de l’idronoxil dans le cadre du traitement de la COVID-19

      La société australienne de développement de médicaments de stade clinique, Noxopharm (ASX : NOX) a publié des données précliniques qui viennent confirmer le rôle de l’idronoxil, médicament...

      August 26 2021
      Business Wire

      Noxopharm Preclinical Data Further Supports Anti-Inflammatory Role of Idronoxil in the Treatment of COVID-19

      Australian clinical-stage drug development company Noxopharm (ASX:NOX) has reported preclinical data that further supports the role of experimental anti-cancer drug, idronoxil, the active...

      August 26 2021
      Business Wire

      ノクソファームの第1相臨床試験でCOVID-19患者に対する抗炎症作用が示される

      第1相臨床試験の良好な結果を受けて、臨床プログラムを世界に拡大へ   （ビジネスワイヤ） -- オーストラリアの臨床段階医薬品開発企業であるノクソファーム（ASX:NOX）は、TBK1（TANK結合キナーゼ1）阻害剤で...

      August 26 2021
      Business Wire

      L’essai clinique de phase I de Noxopharm révèle une réponse anti-inflammatoire chez les patients atteints de COVID-19

      Le programme clinique est développé à l’échelle mondiale suite aux résultats cliniques positifs de phase I La société australienne de développement de médicaments de stade clinique, Noxopharm...

      August 25 2021
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.003-4.166666666670.0720.0740.069279500.07146007DE
      40.0034.545454545450.0660.0760.066602160.06827927DE
      120.0046.153846153850.0650.0880.0581136130.07178849DE
      260.0046.153846153850.0650.110.0511520730.06945804DE
      520.03391.66666666670.0360.1650.0334172940.09081208DE
      156-0.5035-87.94759825330.57250.630.0333599630.18895117DE
      260-0.416-85.77319587630.4850.990.0335036340.34962145DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      CNQOClean TeQ Water Ltd
      AUD 0.01
      (100.00%)
      		116.67k
      AHNOAthena Resources Ltd
      AUD 0.002
      (100.00%)
      		2.75M
      APXAppen Limited
      AUD 0.685
      (59.30%)
      		31.21M
      LPDLepidico Ltd
      AUD 0.003
      (50.00%)
      		251
      APCAustralian Potash Limited
      AUD 0.0015
      (50.00%)
      		517.86k
      PFEOPantera Minerals Ltd
      AUD 0.003
      (-66.67%)
      		71.43k
      TMKOTamaska Oil and Gas Ltd
      AUD 0.001
      (-50.00%)
      		2.63M
      ICLOIceni Gold Limited
      AUD 0.01
      (-50.00%)
      		500k
      HAROHaranga Resources Ltd
      AUD 0.003
      (-40.00%)
      		1M
      ME1Melodiol Global Health Ltd
      AUD 0.0025
      (-37.50%)
      		32.73M
      TEGTriangle Energy Global Limited
      AUD 0.015
      (-11.76%)
      		47.12M
      RCRRincon Resources Limited
      AUD 0.051
      (-33.77%)
      		37.28M
      ME1Melodiol Global Health Ltd
      AUD 0.0025
      (-37.50%)
      		32.73M
      HLXHelix Resources Limited
      AUD 0.003
      (20.00%)
      		31.96M
      APXAppen Limited
      AUD 0.685
      (59.30%)
      		31.21M

      Discussion

      View Full Feed
      Stinger2014 Stinger2014 5 minutes ago
      With the lack of honesty and integrity in the world, nothing surprises me. Many OTC stocks we go in with hope, and we leave as a dope. Let’s see what Logan has up his sleeve. GL all.
      CGAC
      MightyX MightyX 5 minutes ago
      Markets saying sell today?..pay more tomorrow
      SERV
      XMaster2023 XMaster2023 6 minutes ago
      Without a doubt the 7 market makers have made it much more difficult for NWBO to obtain approval. This has delayed this life extending treatment from hitting the market. Given KG position, he could have and should have helped NWBO cross the finish line. In lieu of helping he chose to condemn thous
      NWBO
      uranium-pinto-beans uranium-pinto-beans 8 minutes ago
      F5 Networks price target raised to $215 from $210 at JPMorgan
      JPMorgan analyst Samik Chatterjee raised the firm's price target on F5 Networks to $215 from $210 and keeps a Neutral rating on the shares post the fiscal Q3 report. The firm says that relative to a macro backdrop in relation to en
      capgain capgain 9 minutes ago
      It's really sad out there. (Stupid people in charge)
      Nemesis18 Nemesis18 9 minutes ago
      Right my greedy little piglets here..
      As I have state many times here, the NICE will not make this 'vaccine' a prescriptive treatment at £250,000 a pop.

      Any previous politically driven. vested interest promises made, are now dead.

      And with the old guard heads o
      NWBO
      capgain capgain 10 minutes ago
      You too.
      ksquared ksquared 12 minutes ago
      Beyond sad. Terrifying. Especially since people seem unwilling to think for themselves.
      For those of us who have the pleasure of seeing TV ads, Google has been pitching its AI -- Gemini. (I take umbrage at that since I am one.) One its wonderful abilities is writing a letter
      CaptainObvious CaptainObvious 12 minutes ago
      07/30/24 - 1,246,275,355
      07/26/24 - 1,245,699,314
      07/20/24 - 1,236,477,167
      07/17/24 - 1,233,314,821
      07/13/24 - 1,232,214,821
      07/11/24 - 1,231,614,821
      07/10/24 - 1,230,455,122
      06/29/24 - 1,229,682,280
      06/19/24 - 1,229,013,505
      06/13/24 - 1
      NWBO
      capgain capgain 12 minutes ago
      Not Mine so far!
      Nezitic Nezitic 14 minutes ago
      Don promised to buy 1mln btc to reserve, so can't see any reasonable explanation from u with that new president timeframe in OTC
      GRCU
      ShawnP123 ShawnP123 15 minutes ago
      Pre-market Nvidia is the only company of the Mag 7 which is down. This is not the first time for this to happen in the last 20 days. The interview with Meta probably did more to hurt than help Nvidia. Talking about 5 yrs out and not spending more time on current effects doesn't look like what the ma
      NVDA
      trunkmonk trunkmonk 15 minutes ago
      Smart ones outside of US are gonna grab XRP, they know whats coming. up 3% tonight, sure it settles, but i luv the accumulation going on by people around the world.
      XRPUSD
      nssrr5 nssrr5 15 minutes ago
      Good Morning Doomed - I think this one is my favorite copy and paste job as you made sure to highlight it in all RED lol. I don't think it worked. And what do you know, there is a lot of Great Things out this morning you can copy and paste and repost here that is just the opposite of your normal
      TLRY
      TrendTrade2016 TrendTrade2016 16 minutes ago
      this garbage is not going anywhere...weekly is not in play...watch and learn clowns!!!!
      HIRU
      tradernewstip tradernewstip 17 minutes ago
      $ADMQ Proud to showcase our latest project for the
      @JrLeagueFtWorth
      ! They promote volunteerism, empower women, and improve the community. Learn more at https://juniorleaguefw.org.

      Contact FW Promo at 817-231-8040 or visit https://fwpromo.com for a free quote.
      ADMQ
      Menace212 Menace212 18 minutes ago
      005 breach is my prediction today
      HIRU
      ison929 ison929 18 minutes ago
      Reported Late Monday, NuScale Power Issues Statement Responding To Short-Seller Report, Denies SEC Investigation Claims
      BENZINGA 3:11 AM ET 7/30/2024
      Hunterbrook is a known short-seller that has a vested interest in sensationalizing information to manipulate the stock market. The Secu
      NWBO
      theorysuit theorysuit 19 minutes ago
      Thanks for being real and putting these perspectives in place. I agree with all of the above. Tired of hearing all these optimistic dot connecting and blame game excuses posts by these punpers here. They learned these tactics from their fearless leader LP.
      NWBO
      Drugdoctor Drugdoctor 19 minutes ago
      The OTC has runners every day. You just need to be following the gurus and get in early and get out when they start telling you how great their picks are, because that is what they are doing.
      GVSI
      Bubae Bubae 21 minutes ago
      Court ordered buying? 😆 The Nevada Supreme Court rejected their request for a stay extension Back in February and they pretty much and they summed up this lawsuit in a simple statement. Per the ruling "When a contract is clear on its face, it will be construed from the written language and
      BEGI

      Your Recent History

      ASX
      NOX
      Noxopharm
      Delayed Upgrade Clock